Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-05 Sale |
2023-05-09 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
3,272 | $350 | $1,145,213 | 32,038 (Direct) |
View |
| 2023-05-02 Sale |
2023-05-04 4:51 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
4,403 | $350.71 | $1,544,187 | 35,310 (Direct) |
View |
| 2023-04-12 Sale |
2023-04-14 4:19 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
7,567 | $326.7 | $2,472,164 | 39,713 (Direct) |
View |
| 2023-04-04 Sale |
2023-04-06 4:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
522 | $315.81 | $164,854 | 47,280 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 4:26 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
2,746 | $300.59 | $825,423 | 49,268 (Direct) |
View |
| 2023-02-14 Sale |
2023-02-16 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
2,181 | $300.39 | $655,161 | 59,734 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-14 5:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
113 | $300.39 | $33,944 | 61,915 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 4:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
106 | $325 | $34,450 | 37,998 (Direct) |
View |
| 2022-11-02 Sale |
2022-11-03 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
320 | $312.64 | $100,045 | 38,104 (Direct) |
View |
| 2022-10-18 Sale |
2022-10-20 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,791 | $300.31 | $537,860 | 39,192 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-18 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
45 | $252.83 | $11,377 | 41,749 (Direct) |
View |
| 2022-05-04 Sale |
2022-05-06 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
36 | $275.09 | $9,903 | 41,660 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-04 5:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
320 | $259.16 | $82,930 | 41,696 (Direct) |
View |
| 2022-04-07 Sale |
2022-04-08 4:34 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
561 | $276.18 | $154,935 | 42,782 (Direct) |
View |
| 2022-04-04 Sale |
2022-04-06 5:02 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
3,725 | $274.1 | $1,021,005 | 43,343 (Direct) |
View |
| 2022-03-17 Sale |
2022-03-21 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
2,122 | $250.06 | $530,627 | 48,412 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-03 4:26 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,040 | $250.98 | $261,017 | 54,952 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
112 | $216.34 | $24,230 | 34,108 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 9:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
960 | $218.43 | $209,691 | 34,108 (Direct) |
View |
| 2021-04-05 Sale |
2021-04-07 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,686 | $214.14 | $361,046 | 35,834 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,686 | $210.56 | $355,012 | 38,864 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-14 Option Award |
2023-08-16 6:08 pm |
N/A 2030-11-30 |
Adicet Bio Inc. | ACET | Sanna Bastiano Director |
93,400 | $0 | 93,400 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 5:49 pm |
N/A 2033-05-31 |
Adicet Bio Inc. | ACET | Sanna Bastiano Director |
32,300 | $0 | 32,300 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 4:20 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,466 | $313.74 | 47,802 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 5:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
3,970 | $289.12 | 52,014 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
3,750 | $292.85 | 55,984 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 5:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
4,340 | $298.26 | 61,915 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 5:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
902 | $294.33 | 61,915 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:58 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
29,272 | $0 | 67,270 (Direct) |
View |
| 2022-11-01 Tax Withholding |
2022-11-03 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
768 | $312.84 | 38,104 (Direct) |
View |
| 2022-08-01 Tax Withholding |
2022-08-03 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
766 | $276.62 | 40,983 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:40 pm |
N/A 2032-06-01 |
Adicet Bio Inc. | ACET | Sanna Bastiano Director |
18,500 | $0 | 18,500 (Direct) |
View |
| 2022-04-29 Tax Withholding |
2022-05-03 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
766 | $276.17 | 42,016 (Direct) |
View |
| 2022-04-01 Tax Withholding |
2022-04-05 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,344 | $263.09 | 47,068 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 5:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
3,439 | $232.51 | 50,534 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
979 | $237.74 | 53,973 (Direct) |
View |
| 2022-02-01 Tax Withholding |
2022-02-03 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
526 | $243.64 | 54,952 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
23,942 | $0 | 54,952 (Direct) |
View |
| 2021-11-01 Tax Withholding |
2021-11-03 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
766 | $185.07 | 32,576 (Direct) |
View |
| 2021-07-30 Tax Withholding |
2021-08-03 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
766 | $200.39 | 33,342 (Direct) |
View |
| 2021-04-30 Tax Withholding |
2021-05-05 9:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
766 | $217.21 | 34,108 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-04 7:25 pm |
N/A 2031-04-29 |
Adicet Bio Inc. | ACET | Sanna Bastiano Director |
19,672 | $0 | 19,672 (Direct) |
View |
| 2021-04-01 Tax Withholding |
2021-04-05 4:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,344 | $214.16 | 37,520 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,344 | $214.16 | 40,550 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:56 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
20,719 | $0 | 41,894 (Direct) |
View |
Ownership |
2021-02-05 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
0 | $0 | 21,175 (Direct) |
View |